A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT04487080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04487080
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-08-11
- Enrollment
- 1074
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.